# Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

> **NCT05432375** · EARLY_PHASE1 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Tinostamustine

## Key facts

- **NCT ID:** NCT05432375
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-11-10
- **Final completion:** 2024-11-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432375, "Study of Tinostamustine for Adjuvant Treatment of Glioblastoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05432375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*